HEPATIC HYPERTROPHY

HEPATIC HYPERTROPHY was reported 32 times

HEPATIC HYPERTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 3 0.0009
1 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
2 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0001
3 Lipid-based Polyene Antifungal [EPC] 1 0.0001
4 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
6 Antirheumatic Agent [EPC] 4 0.0000
7 Nucleoside Analog Antiviral [EPC] 3 0.0000
8 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
9 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
10 Polyene Antifungal [EPC] 1 0.0000
11 Estrogen Receptor Antagonist [EPC] 1 0.0000
12 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
13 Azole Antifungal [EPC] 3 0.0000
14 Aromatase Inhibitor [EPC] 2 0.0000
15 Partial Opioid Agonist [EPC] 1 0.0000
16 Purine Antimetabolite [EPC] 1 0.0000
17 5-alpha Reductase Inhibitor [EPC] 1 0.0000
18 Vitamin C [EPC] 4 0.0000
19 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
20 Opioid Agonist [EPC] 2 0.0000
21 Platinum-based Drug [EPC] 2 0.0000
22 Estrogen [EPC] 1 0.0000
23 Endothelin Receptor Antagonist [EPC] 1 0.0000
24 Atypical Antipsychotic [EPC] 2 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
26 Corticosteroid [EPC] 3 0.0000
27 Loop Diuretic [EPC] 1 0.0000
28 Kinase Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000